References
- Bell J E, Brettle R P, Chiswick A, Simmonds P. 1998. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS—effect of neocortical involvement. Brain. 121: 2043–2052. [PUBMED], [INFOTRIEVE]
- Chang L, Ernst T, Leonido-Yee M, Whitt M, Speck O, Walot I, Miller E N. 1999. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology. 53: 782–789. [PUBMED], [INFOTRIEVE]
- Ellis R J, Hsia K, Spector S A, Nelson J A, Heaton R K, Wallace M R, Abramson I, Atkinson J H, Grant I, McCutchan J A. the HNRC Group. 1997. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol. 42: 679–688. [PUBMED], [INFOTRIEVE]
- Everall I P, Heaton R K, Marcotte T D, Ellis R J, McCutchan J A, Grant I, Mallory M, Masliah E. HNRC Group. 1999. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathol. 9: 209–217. [PUBMED], [INFOTRIEVE]
- Everall I P, Luthert P J, Lantos P L. 1991. Neuronal loss in the frontal cortex in HIV infection. Lancet. 337: 1119–1121. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Foudraine N A, Hoetelmans R MW, Lange J MA, de, Wolf F, van, Benthem B HB, Maas J J, Keet I PM, Portegies P. 1998. Cerebrospinal fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine and stavudine. Lancet. 351: 1547–1551. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hong M, Schlichter L, Bendayan R. 2000. A Na(+)-dependent nucleoside transporter in microglia. J Pharmacol Exp Ther. 292: 366–374. [PUBMED], [INFOTRIEVE]
- Kandanearatchi A, Zuckerman M, Smith M, Vyakarnam A, Everall I P. 2002. Granulocyte-macrophage colony-stimulating factor enhances viral load in human brain tissue: amelioration with stavudine. AIDS. 16: 413–420. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Limoges J, Persidsky Y, Poluektova L, Rasmussen J, Ratanasuwan W, Zelivyanskaya M, McCernon D R, Lanier E R, Gendelman H E. 2000. Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice. Neurology. 54: 379–389. [PUBMED], [INFOTRIEVE]
- Masliah E, Heaton R K, Marcotte T D, Ellis R J, wiley C A, Mallory M, achim C L, McCutchan A, Nelson J A, Atkinson J H, Grant I. HNRC Group. 1997. Dendritic injury is a pathological substrate for HIV related cognitive disorders. Ann Neurol. 42: 963–972. [PUBMED], [INFOTRIEVE]
- Takasawa K, Terasaki T, Suzuki H, Ooie T, Sugiyama Y. 1997. Distributed model analysis of 3′-azido-3′-deoxythymidine and 2′,3′-deoxyinosine distribution in brain tissue and cerebrospinal fluid. J Pharmacol Exp Ther. 282: 1509–1517. [PUBMED], [INFOTRIEVE]
- Thomas S A, Segal M B. 1998. The transport of the anti-HIV drug, 2′,3′-didehydro-3′-deoxythymidine (D4T), across the blood-brain and blood-cerebrospinal fluid barriers. Br J Pharmacol. 125: 49–54. [PUBMED], [INFOTRIEVE]
- Trillo-Pazos G, Kandanearatchi A, Eyeson J, King D, Vyakarnam A, Everall I. 2003. HIV-1 causes neuronal loss and damage in human brain balls: a human 3-D model to investigate the cellular brain of HIV associate dementia. Neuropathol Appl Neurobiol, in press.
- Tozzi V, Balestra P, Galgani S. 1999. Positive and sustained effects of highly active antiretroviral therapy on HIV-1 associated neurocognitive impairment. AIDS. 13: 1889–1897. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Yang Z, Brundage R C, Barbhiaiya R H, Sawchuk R J. 1997. Microdialysis studies of the distribution of stavudine into the central nervous system in the freely moving rat. Pharmacol Res. 14: 865–872. [CROSSREF]